Chengdu Easton Biopharmaceuticals Co., Ltd. (SHSE:688513) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its shares. The repurchase price does not exceed CNY 73 per share.

Repurchased shares will be used for employee stock ownership plans or equity incentives. The repurchase program is valid for 12 months from the commencement date.